propylene glycol laurate

lauric acid monoester with propane-1,2-diol

C15 H30 O3 MW: 258.40170000

Identification

Namepropylene glycol laurate
EINECS205-542-3
FDA UNIIM4AW13H75T
Molecular FormulaC15 H30 O3
Molecular Weight258.40170000
Nikkaji NumberJ47.577G

Regulatory

DG SANTE Food Contact Materials1,2-propyleneglycol monolaurate
FDA Mainterm (IAUFC)27194-74-7 ; PROPYLENE GLYCOL MONOLAURATE

Physical Properties

Assay 92.00 to 100.00
Food Chemicals Codex Listed No
Boiling Point 361.00 to 364.00 °C. @ 760.00 mm Hg (est)
Vapor Pressure 0.000001 mmHg @ 25.00 °C. (est)
Flash Point 283.00 °F. TCC ( 139.30 °C. ) (est)
logP (o/w) 4.925 (est)
Soluble in water, 6.301 mg/L @ 25 °C (est)

Cosmetic Information

CosIngcosmetic data
Cosmetic Usesskin conditioning

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categorysurfactant, skin conditioning
Recommendation for propylene glycol laurate usage levels up tonot for fragrance use.
Recommendation for propylene glycol laurate flavor usage levels up tonot for flavor use.

No supplier data available

Potential Uses

emollients emulsifying agents

Natural Occurrence

not found in nature

Synonyms

capmul PG-12 EP/NF dermol PGML dodecanoic acid monoester with 1,2-propane diol emulfree P 2- hydroxypropyl dodecanoate 2- hydroxypropyl laurate lauric acid monoester with propane-1,2-diol propylene glycol monododecanoate propylene glycol monolaurate 1,2- propyleneglycol monolaurate schercemol PGML Ester PubMed: Influence of skin penetration enhancers on skin barrier function and skin protease activity. PubMed: Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems. PubMed: In vitro-in vivo correlation in skin permeation. PubMed: In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrate. PubMed: Formulation of carbenoxolone for delivery to the skin. PubMed: Effects of vehicles on the percutaneous absorption of donepezil hydrochloride across the excised hairless mouse skin. PubMed: Self-microemulsifying formulation-based oral solution of coenzyme Q10. PubMed: Formulation and evaluation of ubidecarenone transdermal delivery systems. PubMed: Pharmacokinetics of formulated tenoxicam transdermal delivery systems. PubMed: Potential mucoadhesive dosage form of lidocaine hydrochloride: II. In vitro and in vivo evaluation. PubMed: Formulation and evaluation of ketorolac transdermal systems. PubMed: The effect of vehicles and pressure sensitive adhesives on the percutaneous absorption of quercetin through the hairless mouse skin. PubMed: Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers. PubMed: A new oral testosterone undecanoate formulation. PubMed: Effect of vehicles and enhancers on the in vitro permeation of melatonin through hairless mouse skin. PubMed: Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. PubMed: In vitro percutaneous absorption of tenoxicam from pressure-sensitive adhesive matrices across the hairless mouse skin. PubMed: Effect of PGML excipient mixture in a transdermal system on the in vitro transport of estradiol across skin. PubMed: A comparison of in vitro skin-penetration cells. PubMed: Transdermal delivery of buprenorphine through cadaver skin.